These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15969304)

  • 1. Randomization-based nonparametric methods for the analysis of multicentre trials.
    LaVange LM; Durham TA; Koch GG
    Stat Methods Med Res; 2005 Jun; 14(3):281-301. PubMed ID: 15969304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them.
    Koch GG; Tangen CM; Jung JW; Amara IA
    Stat Med; 1998 Aug 15-30; 17(15-16):1863-92. PubMed ID: 9749453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-parametric analysis of covariance for confirmatory randomized clinical trials to evaluate dose-response relationships.
    Tangen CM; Koch GG
    Stat Med; 2001 Sep 15-30; 20(17-18):2585-607. PubMed ID: 11523071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials.
    Yamaguchi T; Ohashi Y; Matsuyama Y
    Stat Methods Med Res; 2002 Jun; 11(3):221-36. PubMed ID: 12094756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparametric randomization-based covariate adjustment for stratified analysis of time-to-event or dichotomous outcomes.
    Hussey MA; Koch GG; Preisser JS; Saville BR
    J Biopharm Stat; 2016; 26(3):579-89. PubMed ID: 26101805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing multiple endpoints in a confirmatory randomized clinical trial-an approach that addresses stratification, missing values, baseline imbalance and multiplicity for strictly ordinal outcomes.
    Sun H; Kawaguchi A; Koch G
    Pharm Stat; 2017 Mar; 16(2):157-166. PubMed ID: 28074600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of unstratified and centre-stratified randomization in multi-centre clinical trials.
    Anisimov VV
    Pharm Stat; 2011; 10(1):50-9. PubMed ID: 20112277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity analysis for missing dichotomous outcome data in multi-visit randomized clinical trial with randomization-based covariance adjustment.
    Li S; Koch GG; Preisser JS; Lam D; Sanchez-Kam M
    J Biopharm Stat; 2017; 27(3):387-398. PubMed ID: 28281937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing methods to estimate treatment effects on a continuous outcome in multicentre randomized controlled trials: a simulation study.
    Chu R; Thabane L; Ma J; Holbrook A; Pullenayegum E; Devereaux PJ
    BMC Med Res Methodol; 2011 Feb; 11():21. PubMed ID: 21338524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of multicentre trials with continuous outcomes: when and how should we account for centre effects?
    Kahan BC; Morris TP
    Stat Med; 2013 Mar; 32(7):1136-49. PubMed ID: 23112128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analysis of continuous outcomes in multi-centre trials with small centre sizes.
    Pickering RM; Weatherall M
    Stat Med; 2007 Dec; 26(30):5445-56. PubMed ID: 17924360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary nonparametric analysis of covariance for logistic regression in a randomized clinical trial setting.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 Mar; 9(1):45-66. PubMed ID: 10091909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling clustered survival data from multicentre clinical trials.
    Glidden DV; Vittinghoff E
    Stat Med; 2004 Feb; 23(3):369-88. PubMed ID: 14748034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric analysis of statistic images from functional mapping experiments.
    Holmes AP; Blair RC; Watson JD; Ford I
    J Cereb Blood Flow Metab; 1996 Jan; 16(1):7-22. PubMed ID: 8530558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model.
    Legrand C; Ducrocq V; Janssen P; Sylvester R; Duchateau L
    Stat Med; 2005 Dec; 24(24):3789-804. PubMed ID: 16320274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomization model methods for evaluating treatment efficacy in multicenter clinical trials.
    Davis CS; Chung Y
    Biometrics; 1995 Sep; 51(3):1163-74. PubMed ID: 7548700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sharp nonparametric bounds and randomization inference for treatment effects on an ordinal outcome.
    Chiba Y
    Stat Med; 2017 Nov; 36(25):3966-3975. PubMed ID: 28703430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric response-adaptive randomization for continuous responses.
    Liu Z; Hu F; Zhang LX
    Pharm Stat; 2018 Nov; 17(6):781-796. PubMed ID: 30152167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating covariate-adjusted log hazard ratios in randomized clinical trials using cox proportional hazards models and nonparametric randomization based analysis of covariance.
    Saville BR; Koch GG
    J Biopharm Stat; 2013 Mar; 23(2):477-90. PubMed ID: 23437952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.